Palantir's U.S. commercial business is on fire thanks to AI and could help fuel a further reacceleration of growth, beyond the impressive performance the company has posted recently.

The "Sell America" trade is top of mind after Federal Reserve Chair Jerome Powell said he's under criminal investigation. The dollar is dropping in Monday's session while precious metals rally to records.

As two major streaming platforms—Warner Bros. and Netflix—prepare for a merger, concerns continue to be voiced about the implications of the deal, which represents more consolidation in the media business.

JBHT's fourth-quarter 2025 revenues are expected to have declined year over year. Higher net interest expense might have hurt the bottom line.

APLD shares spike after Q2 revenues soar 250%, underscoring strong execution while leaving questions around valuation and losses.

Global Payments CEO Cameron Bready joins 'Squawk on the Street' to discuss the company's acquisition of Worldpay, address concerns about the deal, and more.

Eli Lilly Chief Financial Officer Lucas Montarce says the company's weight-loss pill is on track to be approved in the US as early as the second quarter of this year. He speaks to Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco.

Abercrombie & Fitch's stock gets punished for a slight tweak in its sales growth outlook, just after it logged its best two-month gain in 25 years.

"Everything I wanted to have happened has worked out," Warren Buffett told CNBC when discussing his 60 years at Berkshire Hathaway. "I couldn't imagine more fun than I've had running Berkshire," he said.

JBL and SANM are both riding AI and digital transformation tailwinds, but key differences in strategy and execution set them apart.

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Gauzy Ltd. (“Gauzy” or “the Company”) (NASDAQ: GAUZ) and certain of its officers.

New class action for Quantum Biopharma Ltd (QNTM) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period").

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Stride securities between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”).

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Integer securities between July 25, 2024 and October 22, 2025, both dates inclusive (the “Class Period”).

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Alexandria securities between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”).

New class action for Skye Bioscience, Inc. (SKYE) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/16/2026

New class action for Bitdeer Technologies (BTDR) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/2/2026

Publicly traded drug developers sold more than $13 billion of shares in the fourth quarter, the most in more than four years.

New class action for Perrigo Company plc (PRGO) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/16/2026.